CRSP

CRISPR THERAPEUTICS AG

Healthcare | Mid Cap

-$1.30

EPS Forecast

$5.67

Revenue Forecast

The company already released most recent quarter's earnings. We will publish our AI's next quarter's forecast around 2024-12-31
NBIXNeurocrine Biosciences IncTECHBio-techne CorpHALOHalozyme Therapeutics IncDNLIDenali Therapeutics IncIOVAIovance Biotherapeutics IncMRNAModerna IncNVAXNovavax IncREPLReplimune Group IncRGENRepligen Corp